News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
US FDA Staff Says TheraTech Inc. Drug Works But Problem Seen
May 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- A proposed drug from Theratechnologies Inc reduced abdominal fat in HIV patients, but the effects did not last when patients stopped treatment, U.S. reviewers said in documents released on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod
March 19, 2026
·
2 min read
·
Heather McKenzie
Policy
FDA Policy Tracker 2026: RMAT Awards for Assets on Hold, Animal Testing Alternatives
March 19, 2026
·
9 min read
·
BioSpace Editorial Staff
Approvals
J&J Wins FDA Nod for First Targeted Oral Anti-IL-23 Therapy for Plaque Psoriasis
March 18, 2026
·
2 min read
·
Tristan Manalac
Podcast
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
March 18, 2026
·
1 min read
·
Heather McKenzie